C-Path and Sanofi collaborate to advance Type 1 Diabetes research

Critical Path Institute (C-Path) announced today that Sanofi, a global leader in immunology and diabetes care, has joined its Type 1 Diabetes Consortium (T1DC). Sanofi joins T1DC as part of its commitment to push the boundaries of innovation to improve the lives of those with diabetes.

Wrist-worn wearable could detect sickle cell pain episodes

Dive Brief: A wrist-worn wearable could provide early warning of the severe acute pain episodes that affect patients with sickle cell disease. Researchers at Children’s

June 16, 2023

FDA Rejects Full Approval of Liver Disease Drug

The FDA declined to grant full approval to obeticholic acid (Ocaliva) for treating primary biliary cholangitis (PBC), Intercept Pharmaceuticals announced on Tuesday. The decision follows

November 13, 2024

Boston Scientific acquires Axonics, urology company, for $3.7 billion

Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion. It’s the

January 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.